Skip to main content

Table 1 Cell cycle analysis with EGCG and BLM in MIA PaCa-2 cells

From: Inhibitory effect of (−)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth

Treatment

G0/G1

S

G2/M

MIA PaCa-2

Control

63

12

25

DMSO

64

12

25

20 μM BLM

45

26

27

20 μM EGCG

67

10

22

20 μM EGCG plus 20 μM BLM

50

20

21

  1. Cell cycle analysis MIA PaCa-2 cell lines when treated with EGCG alone, BLM alone, and both agents together